Lawsuit Alleges ParaGard IUD Broke In Woman’s Cervical Canal

A Missouri woman is one the latest in a growing number of women nationwide to file a lawsuit after a Paragard IUD broke while doctors were attempting to remove the birth control implant, leaving her with severe internal injuries.

The complaint (PDF) was filed by Tiffany Foster in the U.S. District Court for the Western District of Missouri on October 5, indicating the copper intrauterine device (IUD) has a propensity to break at the arms upon explant, even though it is designed to be a completely reversible form of long-acting birth control.

ParaGard involves a T-shaped plastic frame wrapped with copper wire coils, which are designed to produce an inflammatory reaction in the uterus that is toxic to sperm and prevents pregnancy. The birth control implant is supposed to remain in place for up to 10 years, but the manufacturer has indicated it can be safely removed to allow them to conceive when they no longer desire the birth control.

Learn More About

Paragard IUD Lawsuits

Women have reported problems where Paragard IUD fractured or broken during removal, resulting in serious injury.


According to allegations raised in the lawsuit, Teva Pharmaceuticals, Cooper Companies, Inc. and Coopersurgical, Inc. sold a defective and unreasonably dangerous product, which was known to cause serious harm due to the risk of the Paragard IUD breaking upon removal. However, instead of warning about the risk, the manufacturers “concealed, suppressed and failed to disclose or fix this danger,” according to the complaint.

Foster indicates she had a ParaGard IUD implanted in April 2016, at a time the product was widely marketed and generating about $168 million in annual revenue. However, when she went to get the implant removed in April 2020, a piece of the Paragard IUD broke off in her cervical canal. Its presence was confirmed in a June 2020 transvaginal ultrasound, and the debris was removed later that month in a hysteroscope procedure.

“Prior to the procedures, Plaintiff and her doctors were provided with no warning from the DFefendants of the risk of ParaGard IUD failure and injury, nor were Plaintiff and her doctors provided with adequate warning of the risk of removal of ParaGard IUD,” Foster’s lawsuit states. “This information was known or knowable to the Defendants.”

Foster’s claim joins a number of similar Paragard IUD lawsuits filed in recent months, involving similar allegations of problems during removal surgery.

Given common questions of fact and law raised in the complaints, a motion was filed last month with the U.S. Judicial Panel on Multidistrict Litigation seeking to consolidate all Paragard IUD cases before one judge for coordinated discovery and pretrial proceedings.

The manufacturer has not yet responded to the motion, but the U.S. JPML is likely to consider oral argument from various parties involved during an upcoming hearing session scheduled for December 3, 2020 in San Antonio, Texas.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.